Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001530044 | SCV000723822 | likely benign | not provided | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000863253 | SCV001003883 | likely benign | Lethal congenital glycogen storage disease of heart | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001182035 | SCV001347357 | likely benign | Cardiomyopathy | 2018-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002395594 | SCV002703253 | likely benign | Cardiovascular phenotype | 2019-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004002557 | SCV004842194 | likely benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001530044 | SCV001744579 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000613519 | SCV001917808 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001530044 | SCV001930849 | likely benign | not provided | no assertion criteria provided | clinical testing |